文献速递妇科生殖医学

导管导向乙醇硬化治疗对卵巢储备功能低下子宫内膜异位囊肿的疗效及卵巢储备影响

Therapeutic Efficacy of Catheter-directed Ethanol Sclerotherapy and Its Impact on Ovarian Reserve in Patients with Ovarian Endometrioma at Risk of Decreased Ovarian Reserve: A Preliminary Study.
PubMed 文献 · J Minim Invasive Gynecol · 2021-08-29

本研究回顾性纳入18例卵巢子宫内膜异位囊肿≥3 cm且术前血清AMH<2 ng/mL的患者,行导管导向乙醇硬化治疗(CDS)。术后6个月囊肿平均大小和CA-125显著下降,痛经VAS评分均降低,而血清AMH前后差异无统计学意义,提示CDS有效且不进一步损害卵巢储备。

要点

  • CDS可显著缩小囊肿并降低CA-125,改善痛经。
  • 低AMH患者CDS后6个月AMH无显著下降。
  • 适用于囊肿≥3 cm且AMH<2 ng/mL者。

核心结论

  • CDS对低AMH的卵巢子宫内膜异位囊肿患者可有效缓解疼痛和降低CA-125,且不额外损害卵巢储备。

研究设计与样本

  • 回顾性研究,纳入18例卵巢子宫内膜异位囊肿≥3 cm且术前血清AMH<2 ng/mL的患者,在教学医院接受CDS。

主要发现

  • CDS后6个月囊肿平均大小和血清CA-125水平较术前下降(p<.001和p=.001)。
  • 所有患者痛经VAS评分均下降(p<.001)。
  • CDS前后血清AMH水平差异无统计学意义(p=.875)。

关键数值与推荐

  • 纳入标准:卵巢子宫内膜异位囊肿≥3 cm,术前血清AMH<2 ng/mL。
  • 干预:置入8.5-F导管(经腹或经阴道),抽吸后注入99%乙醇,保留20分钟。

临床怎么用

  • 对卵巢子宫内膜异位囊肿≥3 cm且AMH<2 ng/mL、有生育需求的患者,CDS可作为保留卵巢储备的微创治疗选择。

局限性

  • 回顾性设计,样本量小(18例),随访仅6个月,为初步研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY OBJECTIVE: To investigate the therapeutic efficacy of catheter-directed ethanol sclerotherapy (CDS) and its effect on ovarian reserve in patients with endometrioma at risk of decreased ovarian reserve. DESIGN: Retrospective study. SETTING: Teaching hospital. PATIENTS: We evaluated 18 patients with ovarian endometrioma measuring ≥3 cm and preprocedural serum antimüllerian hormone (AMH) levels of <2 ng/mL. INTERVENTIONS: An 8.5-F catheter was inserted either transabdominally or transvaginally into the endometrioma. After aspiration, sclerotherapy with 99% ethanol was performed, with a subsequent 20-minute ethanol retention. MEASUREMENTS AND MAIN RESULTS: Ultrasonography was performed preprocedurally and 6 months after CDS to evaluate any recurrence or changes in cyst size. Furthermore, serum AMH levels, cancer antigen 125 (CA-125) levels, and the visual analog scale scores for dysmenorrhea were obtained to analyze the ovarian reserve and treatment efficacy, preprocedurally and at 6 months after CDS. The mean cyst size on ultrasonography and serum CA-125 levels decreased 6 months after CDS (p <.001 and p = .001, respectively). All patients reported a decreased visual analog scale score for dysmenorrhea (p <.001). However, the difference in serum AMH levels before and after CDS was statistically insignificant (p = .875). CONCLUSION: CDS was efficacious in reducing pain and serum CA-125 levels in patients with low AMH levels without adversely affecting their ovarian reserve.

来源:J Minim Invasive Gynecol,查看原文。版权归原作者所有。

引用

  1. Lee JK, Ahn SH, Kim HI, et al. Therapeutic Efficacy of Catheter-directed Ethanol Sclerotherapy and Its Impact on Ovarian Reserve in Patients with Ovarian Endometrioma at Risk of Decreased Ovarian Reserve: A Preliminary Study. J Minim Invasive Gynecol. 2021. PMID: 34469826. doi:10.1016/j.jmig.2021.08.018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。